At the same time, we collected the immunohistochemical and genetic detection results of glioma patient samples, including Vimentin, S-100, GFAP, SYN, EMA, CD34, Ki67, IDH mutation, MEMG methylation and 1p/19q lost and other information (Table 6). This evidence concerns the gene CD34 and central nervous system cancer.